Preclinical Models Core
临床前模型核心
基本信息
- 批准号:10617220
- 负责人:
- 金额:$ 26.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Animal ExperimentationAnimal ModelAnimalsAreaAutopsyBiological AssayBiological MarkersCaliforniaClinical DataClinical PathologyComparative PathologyComplementConsultConsultationsCore FacilityData AnalysesDevelopmentDigestive System DisordersDiseaseDoctor of PhilosophyExperimental DesignsFundingGastrointestinal DiseasesGastrointestinal tract structureGene ExpressionGenetic Predisposition to DiseaseHealthHistologyHistopathologyHumanImageImaging TechniquesInfectionInflammationInfrastructureLeadershipLiverLiver diseasesMedicineMethodsMicroscopyMissionModelingMonitorNational Institute of Diabetes and Digestive and Kidney DiseasesOutcomePathologyPatientsPre-Clinical ModelR24RecordsResearchResearch PersonnelResourcesRoleScientistServicesStainsSurveysSystemTechniquesTrainingTranslatingUniversitiesVeterinariansanimal imagingcomparativecost effectivedata acquisitiondisease phenotypeexperiencefunctional genomicsgastrointestinal systemhuman diseasein vivoin vivo imaginginsightinstrumentationlecturesmembermicrobiome researchmouse modelpatient populationpre-clinicalpre-clinical researchpreclinical studyprogramsprospectiverecruitrepositoryresearch facultysample fixationskillssuccesstissue preparationveterinary science
项目摘要
Summary
The Preclinical Models Core in the San Diego Digestive Diseases Research Center will provide access
to animal models of gastrointestinal and liver disease for preclinical studies and will assist in characterizing
disease activity prospectively and retrospectively in a comprehensive and uniform manner. The Core
emanated out of core services provided by a past NIDDK-funded (R24) Mini-Center at the University of
California, San Diego (UCSD). The approach to create the Preclinical Models Core is based on information
from surveys of Center member needs, experience with the prior Mini-Center at UCSD, the broad expertise of
Center members in digestive diseases research, and the insights of several of the Center members who have
served as advisors or in leadership roles for other Silvio O. Conte Centers. The Core will provide resources in
veterinary sciences and a technical infrastructure that enables animals to be studied comprehensively. The
services will include consultation on the selection and interpretation of animal models of digestive diseases,
ante-mortem imaging and post-mortem examination, including the development and interpretation of scoring
systems by veterinarians trained in comparative pathology. Thus, the Core will truly be “preclinical” in that it will
be modeling and evaluating disease with instrumentation also used in patients with the added advantage of the
controlled manipulations that are possible in these models. The Core will be led by two experienced leaders
with strong track records in applying animal models to basic and preclinical questions: Dr. Peter Ernst, a PhD
veterinarian with extensive experience in managing Core facilities, will be the Core Director and focus on
murine models of gastrointestinal disease and in vivo imaging. As the Core Co-Director, Dr. Tatiana Kisseleva
will provide her extensive experience with animal models of liver disease. Furthermore, the Core will interact
with and directly complement the Human Translational and Microbiomics and Functional Genomics Cores by
being able to relate the imaging results, biomarkers and clinical data to specific outcomes in animal models
and human disease. Thus, the Preclinical Models Core will benefit the investigators in the Center by providing
reliable, cost-effective services that are coordinated with the investigators’ research and other Cores to
facilitate and advance research related to the gastrointestinal tract and liver.
概括
圣地亚哥消化疾病研究中心的临床前模型核心将提供访问
进行胃肠道和肝病的动物模型进行临床前研究,并将有助于表征
疾病活动以全面而统一的方式前瞻性和追溯。核心
由过去的NIDDK资助(R24)迷你中心提供的核心服务发出
加利福尼亚,圣地亚哥(UCSD)。创建临床前模型核心的方法基于信息
从中心会员需求的调查,在UCSD的先前的小型中心经验中,
消化系统疾病研究的中心成员,以及有几个中心成员的见解
担任其他Silvio O. Conte中心的顾问或领导职务。核心将提供资源
兽医科学和技术基础设施,可以彻底研究动物。这
服务将包括有关消化疾病动物模型的选择和解释的咨询,
验尸成像和验尸检查,包括评分的发展和解释
受过比较病理学培训的兽医的系统。那就真正的核心将是“临床前”
用仪器对疾病进行建模和评估仪器,也用于患者中
这些模型中可能的受控操作。核心将由两个经验丰富的领导人领导
在将动物模型应用于基本和临床前问题时具有很强的记录:Peter Ernst博士,博士学位
兽医在管理核心设施方面拥有丰富经验,将成为核心主任,并专注于
胃肠道疾病和体内成像的鼠模型。作为核心联合导演,Tatiana Kisseleva博士
将为她在肝病动物模型方面提供丰富的经验。此外,核心将相互作用
与并直接补充人类翻译和微生物组和功能基因组学核心
能够将成像结果,生物标志物和临床数据与动物模型中的特定结果联系起来
和人类疾病。那就是临床前模型核心将通过提供
可靠,具有成本效益的服务与研究人员的研究和其他核心协调
促进并提高与胃肠道和肝脏有关的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tatiana Kisseleva其他文献
Tatiana Kisseleva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tatiana Kisseleva', 18)}}的其他基金
The role of IL-17 signaling in alcohol-induced HCC
IL-17 信号在酒精诱导的 HCC 中的作用
- 批准号:
10463697 - 财政年份:2021
- 资助金额:
$ 26.43万 - 项目类别:
The role of IL-17 signaling in alcohol-induced HCC
IL-17 信号在酒精诱导的 HCC 中的作用
- 批准号:
10299157 - 财政年份:2021
- 资助金额:
$ 26.43万 - 项目类别:
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
用于治疗酒精相关性肝病的新型 IL-23 抑制剂
- 批准号:
10482350 - 财政年份:2020
- 资助金额:
$ 26.43万 - 项目类别:
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
用于治疗酒精相关性肝病的新型 IL-23 抑制剂
- 批准号:
10266186 - 财政年份:2020
- 资助金额:
$ 26.43万 - 项目类别:
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
门静脉成纤维细胞在胆汁淤积性肝纤维化中的作用
- 批准号:
10441586 - 财政年份:2014
- 资助金额:
$ 26.43万 - 项目类别:
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis
肝纤维化逆转过程中肝星状细胞失活
- 批准号:
8694267 - 财政年份:2014
- 资助金额:
$ 26.43万 - 项目类别:
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
门静脉成纤维细胞在胆汁淤积性肝纤维化中的作用
- 批准号:
10312314 - 财政年份:2014
- 资助金额:
$ 26.43万 - 项目类别:
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH
NASH 中人肝星状细胞 (HSC) 的表观遗传学
- 批准号:
10367096 - 财政年份:2014
- 资助金额:
$ 26.43万 - 项目类别:
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis
肝纤维化逆转过程中肝星状细胞失活
- 批准号:
9271180 - 财政年份:2014
- 资助金额:
$ 26.43万 - 项目类别:
相似国自然基金
构建环状RNA调控肝癌干细胞干性维持的实验动物模型及机制研究
- 批准号:32070533
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
大鼠创伤性颞下颌关节强直实验动物模型的构建及发生机制研究
- 批准号:81970954
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
髌骨脱位后股骨滑车发育不良的实验动物模型研究
- 批准号:81873983
- 批准年份:2018
- 资助金额:75.0 万元
- 项目类别:面上项目
舒张性心衰(HFpEF)的动物模型:机理研究和实验治疗
- 批准号:81770265
- 批准年份:2017
- 资助金额:80.0 万元
- 项目类别:面上项目
基于神经中央软骨生长调控的早发性脊柱侧弯矫正模式的动物实验研究
- 批准号:81772422
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
GUMC Zebrafish Shared Resource Aquatic Habitat Modernization Project
GUMC斑马鱼共享资源水生栖息地现代化项目
- 批准号:
10734150 - 财政年份:2023
- 资助金额:
$ 26.43万 - 项目类别:
Commercial translation of high-density carbon fiber electrode arrays for multi-modal analysis of neural microcircuits
用于神经微电路多模态分析的高密度碳纤维电极阵列的商业转化
- 批准号:
10761217 - 财政年份:2023
- 资助金额:
$ 26.43万 - 项目类别:
A New Cage Wash for Laboratory Animal Resources at Iowa State
爱荷华州实验动物资源的新笼式清洗
- 批准号:
10737441 - 财政年份:2023
- 资助金额:
$ 26.43万 - 项目类别:
Unravelling highly pathogenic influenza virus emergence
揭开高致病性流感病毒出现的谜团
- 批准号:
10718091 - 财政年份:2023
- 资助金额:
$ 26.43万 - 项目类别:
Infectious history as a determinant of age-related inflammation in Alzheimers disease
感染史是阿尔茨海默病年龄相关炎症的决定因素
- 批准号:
10663042 - 财政年份:2023
- 资助金额:
$ 26.43万 - 项目类别: